Some show marked differential expression in a single non-SHH subgroup,such as NFIA (Group 3 tumours) and FGF13 (Group 4 tumours), orin more than one subgroup (e.g. TGIF2 and MYT1L), suggestingthat these genes may be relevant to MB in general. This evidence concerns the gene MYT1L and neoplasm.